anthonyyazdaniml/gliner-biomed-curated-corpus huggingface dataset:
This invention relates to the use of liquid membrane technology in preparing medicinals. The medicinals prepared by this invention may be ingested and may be utilized as traps for toxins present in the GI (gastrointestinal) tract, or as slow-release compositions of drugs, or as reactors. In the trap embodiment, the liquid membrane encapsulated medicinal is an emulsion comprising an exterior phase which is immiscible with the liquids present in the GI tract and permeable to the toxins therein, and an interior phase which is immiscible with the exterior phase and comprises a reagent capable of converting said toxin into a nonpermeable form. In addition, hydrophilic adsorbents, such as a hydrophilic carbon or a silica gel, may be encapsulated in the emulsions of the instant invention. When the compositions of the instant invention are utilized as slow-release drugs, the interior phase of the emulsion will comprise a drug which is slightly soluble in the exterior phase of the emulsion whereby said drug permeates through said exterior phase of the emulsion over a period of time into the GI tract. The third method for utilizing the compositions of the instant invention comprises encapsulating a catalyst for a reaction which is desired to be carried out in the GI tract. In this embodiment the reactants present in the GI tract permeate through the exterior phase of the emulsion into an interior phase wherein said catalyst, for example, an enzyme, converts the permeated reactants to reaction products. The reaction products then may permeate through the exterior phase back into the GI tract. In all cases, the liquid membrane encapsulated medicinals may be administered by either oral ingestion or injection anywhere else into the GI tract.
The primary data demonstrating the efficacy of thalidomide in the treatment of the cutaneous manifestations of moderate to severe ENL are derived from the published medical literature and from a retrospective study of 102 patients treated by the U.S. Public Health Service.

Two double-blind, randomized, controlled trials reported the dermatologic response to a 7-day course of 100 mg thalidomide (four times daily) or control. Dosage was lower for patients under 50 kg in weight.

Waters reported the results of two studies, both double-blind, randomized, placebo-controlled, crossover trials in a total of 10 hospitalized, steroid-dependent patients with chronic ENL treated with 100 mg thalidomide or placebo (three times daily). All patients also received dapsone. The primary endpoint was reduction in weekly steroid dosage.

Data on the efficacy of thalidomide in prevention of ENL relapse were derived from a retrospective evaluation of 102 patients treated under the auspices of the U.S. Public Health Service. A subset of patients with ENL controlled on thalidomide demonstrated repeated relapse upon drug withdrawal and remission with reinstitution of therapy.

Twenty U.S. patients between the ages of 11 and 17 years were treated with thalidomide, generally at 100 mg daily. Response rates and safety profiles were similar to that observed in the adult population.

Thirty-two other published studies containing over 1600 patients consistently report generally successful treatment of the cutaneous manifestations of moderate to severe ENL with thalidomide.
BACKGROUND AND AIMS: The burden of alcohol-related complications is high and rising. However, there are notable deficiencies in comprehensive epidemiological study focusing on cardiovascular complications from alcohol, especially among young and middle-aged adults. We thus aimed to determine the burden of these conditions in young and middle-aged adults globally.
METHODS AND RESULTS: We used data from the Global Burden of Disease Study 2019 and analysed the mortality and disability-adjusted life years of alcohol-associated cardiovascular complications in young and middle-aged adults. The findings were classified by sex, region, country, and Sociodemographic Index (SDI). The highest age-standardized death rates (ASDR) were observed in stroke 0.84 (95% UI 0.60-1.09), followed by alcoholic cardiomyopathy 0.57 (95% UI 0.47-0.66) per 100,000 population. The overall burden of alcohol-associated cardiovascular complications decreased globally but increased in atrial fibrillation and hypertensive heart disease. Regionally, most regions underwent a decrease in ASDR, but an increase was observed in Southeast Asia (+2.82%), Western Pacific (+1.48%), low-middle (+1.81%), and middle SDI (+0.75%) countries. Nevertheless, the ASDR and ASDALYs were highest in Europe.
CONCLUSIONS: The impact of alcohol-associated atrial fibrillation and hypertensive heart disease has increased over the last decades. Regarding region, the burden in Europe and the rising burden in Asia, require immediate public health policy to lessen these cardiovascular complications from alcohol in young and middle-aged adults.
Baseline guideline-directed medications therapy (GDMT), including angiotensin-converting enzyme inhibitors (ACEI) or angiotensin II receptor blocker (ARB), beta-blockers, mineralocorticoid receptor antagonist (MRA), and angiotensin receptor neprilysin inhibitor (ARNI) were documented at discharge. More-GDMT group was defined as patient population received GDMT \>=2 kinds of above medications.
In humans, nephrogenesis is completed by 32-36 weeks gestation, with a highly variable total number of nephrons, ranging from 200,000 to over 2 million. Premature birth disrupts the development and maturation of the kidneys, leading to a reduction in the final number of nephrons. Due to significant genetic variability in the number of nephrons among individuals, it is crucial to identify premature infants with fewer nephrons at birth as early as possible. These infants are more susceptible to developing renal failure with advancing age compared to those with a higher nephron endowment. Bedside ultrasound, an effective and non-invasive tool, is practical for identifying newborns with a lower nephron count. However, renal volume alone cannot reliably indicate the number of nephrons due to substantial variability at birth, influenced by gestational age when nephron maturation is incomplete. This variability in kidney volumes persists as newborns grow. In this observational study we hypothesize that the relationship between renal volume and birth weight may serve as an indicator of nephron endowment in premature infants with birth weight less than 1000 g. This finding could represent the basis for defining appropriate surveillance protocols and developing targeted therapeutic approaches.
It was designed as a randomized controlled prospective. After 2 weeks of splint follow-up, the splints of the patients who were operated due to distal radius fracture and volar plate were applied will be removed and included in the physical therapy program. The measurements and scores of the patients at the time of removal of the splint will be recorded. Patients' non-injured contralateral extremity data will also be recorded. The dominant party will be registered. Preoperative fracture classification of the patients, reduction parameters after surgery, waiting time for post-fracture surgery, pre-fracture chronic diseases, cognitive disorders, psychiatric disease histories, whether the patients lived alone at home or not will be recorded. Patients will be randomized with the help of a free computer aided numerator. The patients will be divided into two groups and conventional face-to-face rehabilitation will be applied to one group, and the previously planned tele-rehabilitation program will be applied to the other group. Videos of the exercises they will do via whatsapp will be sent to the telerehabilitation group. Again, in telerehabilitation, whatapp application will be made in the form of videoconference. Rehabilitation program will be applied to the patients 4 times a week for 6 weeks. Rehabilitation will be applied to the groups by the same person. At the end of the rehabilitation program, the first measurements of the patients will be taken. The third measurement of the patients will be taken at the 3rd month after the surgery. Among the parameters to be checked, grip strength, wrist range of motion, Shortened Disabilities of the Arm, Shoulder, and Hand (QuickDASH) and Patient-Rated Wrist Evaluation (PRWE) questionnaire, VAS scale will be used. Solid side values will be recorded. Tele-rehabilitation satisfaction survey will be applied in the 3rd month controls of the patients.
The patients who undergo treatment with a complex of polypeptides isolated from the vessels of cattle is administered in / m, adults 1 vial (5 mg) 1 time / day 2 times a week. The course of treatment is 10 injections.
Different human leukocyte antigen (HLA) genotypes have been known to be associated with the risk of development of Sjögren's syndrome in different populations, but this association has never been reported in Taiwan. We enrolled 1044 subjects (673 patients, 371 controls) and tested their HLA-DR genotypes. We found an increased risk of Sjögren's syndrome in patients carrying HLA-DR8. DR1 and DR14 were associated with increased risk of eye involvement (uveitis, scleritis or optic neuritis), while DR15 was associated with increased risk of interstitial lung disease. DR8 was associated with increased risk of formation of multiple antibodies: anti-Ro, rheumatoid factor and antinuclear antibodies (ANA) reaching titer 1:80 or above. DR9 was associated with decreased risk of formation of anti-La antibodies and increased risk of formation of antithyroglobulin antibodies. DR10 was associated with risk of formation of anticyclic citrullinated peptide (anti-CCP) antibodies, and DR11 was associated with increased risk of formation of anti-La antibodies. Oral ulcer was found to be negatively associated with anti-Ro antibodies and with anti-ENA antibodies. Skin lesions were associated with ANA antibody titer elevation to 1:80 or above. Malignancies of any kind were associated with the presence of cryoglobulin. Females were more likely to be diagnosed at a younger age than males. There was no statistically significant relationship between HLA-DR genotype and age at disease diagnosis. In patients with Sjögren's syndrome in Taiwan, the presence of HLA-DR8 appeared to be a risk factor. In addition, we found several associations between HLA-DR genotype, clinical presentation, and autoantibody status among them.
PURPOSE: To prepare a phosphopeptide by subjecting an enzyme hydrolysate of casein containing univalent cationic salt of phosphorus casein or its deriv. to ultrafiltration and adding a specified bivalent cation to the filtrate. CONSTITUTION: One or more kinds of protein decomposing enzymes which reproduce digestion of protein in a human body are brought into reaction with casein containing a univalent cation of phosphorus casein or its deriv. to decompose with enzyme. The produced hydrolysate is introduced to one or more ultrafiltration processes. One or more kinds of bivalent cationic salts which produce phosphate part and aggregates of peptide are added to the filtrate liquid. Then the obtd. soln. containing phosphopeptide aggregates and nonphosphate peptide is treated by ultrafiltration process, and if necessary, the bivalent cation is partially replaced with minute elements such as Fe, Zn to obtain phosphopeptide.
FIELD: medicine. SUBSTANCE: method is carried out by disintoxication therapy with the help of antimonous-silicium sorbent, its dose being 1.5-2.0 g in 50-100 ml of distilled water twice a day. Additionally manual affection is carried out on the 3-4 day from the beginning of treatment course. The process takes place on the area of vertebral column at level Jh 5 -L 4 , stress being 20-25 kg/cm 2 . Method is available for III-IV degree of dehydration, survival rate being 100% . EFFECT: increases efficiency of the method.
There are limited data on overdose with bisoprolol fumarate and hydrochlorothiazide. However, several cases of overdose with bisoprolol fumarate have been reported (maximum: 2000 mg). Bradycardia and/or hypotension were noted. Sympathomimetic agents were given in some cases, and all patients recovered.

The most frequently observed signs expected with overdosage of a beta-blocker are bradycardia and hypotension. Lethargy is also common, and with severe overdoses, delirium, coma, convulsions, and respiratory arrest have been reported to occur. Congestive heart failure, bronchospasm, and hypoglycemia may occur, particularly in patients with underlying conditions. With thiazide diuretics, acute intoxication is rare. The most prominent feature of overdose is acute loss of fluid and electrolytes. Signs and symptoms include cardiovascular (tachycardia, hypotension, shock), neuromuscular (weakness, confusion, dizziness, cramps of the calf muscles, paresthesia, fatigue, impairment of consciousness), gastrointestinal (nausea, vomiting, thirst), renal (polyuria, oliguria, or anuria [due to hemoconcentration]), and laboratory findings (hypokalemia, hyponatremia, hypochloremia, alkalosis, increased BUN [especially in patients with renal insufficiency]).

If overdosage of bisoprolol fumarate and hydrochlorothiazide is suspected, therapy with bisoprolol and hydrochlorothiazide should be discontinued and the patient observed closely. Treatment is symptomatic and supportive; there is no specific antidote. Limited data suggest bisoprolol fumarate is not dialyzable; similarly, there is no indication that hydrochlorothiazide USP is dialyzable. Suggested general measures include induction of emesis and/or gastric lavage, administration of activated charcoal, respiratory support, correction of fluid and electrolyte imbalance, and treatment of convulsions. Based on the expected pharmacologic actions and recommendations for other beta-blockers and hydrochlorothiazide USP, the following measures should be considered when clinically warranted:

Bradycardia: Administer IV atropine. If the response is inadequate, isoproterenol or another agent with positive chronotropic properties may be given cautiously. Under some circumstances, transvenous pacemaker insertion may be necessary.

Hypotension, Shock: The patient’s legs should be elevated. IV fluids should be administered and lost electrolytes (potassium, sodium) replaced. Intravenous glucagon may be useful. Vasopressors should be considered.

Heart Block (second or third degree): Patients should be carefully monitored and treated with isoproterenol infusion or transvenous cardiac pacemaker insertion, as appropriate. 

Congestive Heart Failure: Initiate conventional therapy (i.e., digitalis, diuretics, vasodilating agents, inotropic agents).

Bronchospasm: Administer a bronchodilator such as isoproterenol and/or aminophylline.

Hypoglycemia: Administer IV glucose.

Surveillance: Fluid and electrolyte balance (especially serum potassium) and renal function should be monitored until normalized.
PURPOSE:To provide a drug for external use, having improved releasability of the principal drug without causing the decomposition of the drug, and useful for the surgical treatment and prevention of various infectious diseases, by adding negamycin or its salt as an active component to a gelatinous base, and adding cyclodextrin to the mixture. CONSTITUTION:Negamycin (abbreviated as NGM) or its salt and cyclodextrin are added to a gelatinous base. NGM is effective for the remedy of various infectious diseases (e.g. impetigo, folliculitis, sycosis vulgaris, superficial pyoderma, etc.) caused by Gram-positive bacteria and Gram-negative bacteria represented by Pseudomonas aeruginosa, and its resistant strain, however, it has the problems of stability in the base and the releasability from the base when used as an external drug. It has been found that the concentration of NGM can be increased rapidly to the bactericidal level and the decomposition of the principal drug can be prevented by using the agent in combination with cyclodextrin and a gelatinous base (e.g. carboxyvinyl polymer). Since a gelatinous base is used in the present drug, it is free from fat and oil, suitable even to seborrheic diseases, and fixed firmly to the mucosa and damaged moist part.
A radiographic imaging system (200) includes a quality control workstation (202) for processing a digital radiographic image signal in either a pass-through mode or a manual mode. In the pass-through mode, the digital radiographic image signal is automatically processed according to preselected image parameter values to produce one or more versions of image processed digital radiographic images which are automatically routed to preselected destinations. In the manual mode, a preselected version of image processed digital radiographic image is displayed to be verified by a user. The user can also change image parameters to change the displayed radiographic image. The user then routes the image processed radiographic image signals to preselected destinations or user selected destinations. Preferably, the digital radiographic image signal is produced by a storage phosphor reader (10) which converts a latent radiographic image stored on a storage phosphor into said digital radiographic image signal.
The utility model provides a multi-effect medicine health-care seat pad for preventing and curing disease, health preserving and health care. The inner part of the seat pad contains a paper envelope, and the paper envelope is formed by that according to the principle of traditional Chinese medicine, direction and prescription are created, the powder of traditional Chinese medicine with 29 tastes are adopted to be filled in a pocket, the powder is transfixed and formed, and the transfixed powder is arranged on a base pad. The pad has the functions of wind wetness expelling, pain and numbness elimination, grain stretching, qi and blood operation, liver and kidney nourishing, bones and muscles strengthening, heat-clearing, detoxicating and antiinflammation. The utility model favorable preventive and therapeutic effect on diseases such as the symptom of rheumatosis, lumbocrural pain, sciatica, hemorrhoid, nephritis, prostatitis, prostatic hypertrophy, etc. The outer pat of the pad is sheathed with a shoulder strap zipper and the inner part is provided with a spacing pocket. A content can be taken out to wash a coat at any time, at outgoing time, the utility model can be filled with portable articles such as money, paper, books, etc.
A method of regulating an osteoclast formation signal. It is found out that the osteoclast formation process can be inhibited by activating I type IFN signal transduction. By activating the I type IFN signal, the expression of c-Fos protein induced by RANKL is down-regulated and thus the formation of osteoclasts is inhibited. I type IFNs (IFN-α and IFN-β) show an effect of dose-dependently inhibiting osteoclast formation. It is found out that a signal mediated by StatI and IRF-9 is important in the inhibition of osteoclast formation by I type IFNs. Thus, a novel therapeutic strategy against diseases in association with abnormal bone disruption involving autoimmune arthritis can be provided.
Background: PCI has been done traditionally through transfemoral route. But now transradial and transbrachial routes are also coming up in practice. We compared transradial versus transfemoral routes for ease of operability, time for procedure, complications, and failure rates through a prospective study. Methods: 400 Patients admitted in department of cardiology for percutaneous interventions were enrolled in the study. 200 patients were assigned to each group randomly. A single team did all the procedures. Pre procedure, intra procedure and post procedure data of all the patients was collected, tabulated and analysed properly.

The variables studied include Access time ,Fluoroscopy time and overall procedure time, post procedure complications( ecchymosis ,Thrombophelibites, Hematoma, procedure access bleed), Failure rates,post procedure myocardial infarction, stroke, acute renal failure and infections.
The chikungunya virus (CHIKV) is an arbovirus passed to humans by Aedes mosquitoes. Since its description in 1952, CHIKV has caused millions of human infections in Africa, the Indian Ocean islands, Asia, Europe and America (1). In total, since 2013, the epidemic has affected more than 2 million people in the Americas. In Guadeloupe, the emergence of chikungunya cases began in 2013. CHINKV was declared an epidemic in 2014 with an estimated 20,000 infected patients.Human infection with CHIKV is characterized by a sudden onset of severe joint pains, high fever and rash. The infection is self-limited and acute symptoms usually disappear within one or two weeks. However, this polyarthralgia is recurrent in 30 to 40% of infected people and can persist for years. Chikungunya is considered chronic if the symptoms persist after three months. The chronic stage can last from a few months to several years. Chronic chikungunya usually manifests as joint pain and stiffness, polyarthralgia (including rheumatoid arthritis, flare-ups of spondylitis), and other general symptoms such as intermittent headaches, edema, and paresthesia. The consequences of chronic CHIKV can be severe, with patients becoming maladjusted to their lifestyle, feeling weakened and diminished. Depression and medical leaves are very frequent, with many cases of disability. Yoga is an ancestral Indian practice aiming to connect the "body" and the "soul", the "self" and "the other". Traditionally, it is a philosophical way of living, sometimes combined with the practice of physical exercises. In westernized countries, Yoga is usually considered as a physical practice or an alternative therapy, using various techniques of breathing, relaxation and poses to release tensions and decrease pain.

Studies have already shown the effectiveness of yoga practice on various arthralgia's, on the reduction of inflammatory reactions, on psychological disorders/sleep disorders and on quality of life. Considering quality of life as a global experience of balance between physical and mental wellbeing, the hypothesis was that the practice of yoga, by improving these different aspects, would globally improve the quality of life of patients with chronic chikungunya.
<P>PROBLEM TO BE SOLVED: To provide a biodegradable and biocompatible polymer material with mechanical property and chemical proterty suitable for use in biochemical application as bone cement and a tissue implant.  <P>SOLUTION: Compositions for bone repair have been developed based on linear hydrophobic biodegradable polymers and monomers or macromers, at least one of which includes an anhydride linkage. The monomers and/or macromers crosslink each other but not to the linear polymer to form semi-interpenetrating networks. The compositions can include various excipients, therapeutic and/or diagnostic agents. The compositions can be polymerized in the presence of dissolvable particles such as inorganic salts and proteinaceous materials to provide a porous polymer network. The compositions can be injected into a patient and polymerized in situ or can be polymerized ex vivo and implanted.  <P>COPYRIGHT: (C)2010,JPO&INPIT
Subjects will be randomized to receive JNJ-18038683 or placebo after the completion of the baseline assessments. Subjects randomized to JNJ-18038683 will receive 10 mg for one week, then titrate to 20 mg for the duration of the trial, with the provision for a single, downward dose adjustment for intolerance, based upon investigator judgment.